LDDD (Longduoduo Co) FCF Margin % : -76.85% (As of Sep. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Longduoduo Co FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Longduoduo Co's Free Cash Flow for the three months ended in Sep. 2024 was $-0.59 Mil. Longduoduo Co's Revenue for the three months ended in Sep. 2024 was $0.77 Mil. Therefore, Longduoduo Co's FCF Margin % for the quarter that ended in Sep. 2024 was -76.85%.

As of today, Longduoduo Co's current FCF Yield % is 0.06%.

The historical rank and industry rank for Longduoduo Co's FCF Margin % or its related term are showing as below:

LDDD' s FCF Margin % Range Over the Past 10 Years
Min: -2.56 Med: 12.86 Max: 67.63
Current: 1.37

During the past 4 years, the highest FCF Margin % of Longduoduo Co was 67.63%. The lowest was -2.56%. And the median was 12.86%.

LDDD's FCF Margin % is ranked better than
59.45% of 217 companies
in the Medical Diagnostics & Research industry
Industry Median: -5.38 vs LDDD: 1.37

Longduoduo Co FCF Margin % Historical Data

The historical data trend for Longduoduo Co's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Longduoduo Co FCF Margin % Chart

Longduoduo Co Annual Data

Trend

Jun21

Jun22

Jun23

Jun24

FCF Margin %

67.63

-2.56

21.97

3.75

Longduoduo Co Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
FCF Margin %	Get a 7-Day Free Trial									-25.46	75.05	-34.25	-27.69	-76.85

Competitive Comparison of Longduoduo Co's FCF Margin %

For the Diagnostics & Research subindustry, Longduoduo Co's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Longduoduo Co's FCF Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Longduoduo Co's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Longduoduo Co's FCF Margin % falls into.

Longduoduo Co FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Longduoduo Co's FCF Margin for the fiscal year that ended in Jun. 2024 is calculated as

FCF Margin	=	Free Cash Flow (A: Jun. 2024 )	/	Revenue (A: Jun. 2024 )
	=	0.277	/	7.39
	=	3.75 %

Longduoduo Co's FCF Margin for the quarter that ended in Sep. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Sep. 2024 )	/	Revenue (Q: Sep. 2024 )
	=	-0.591	/	0.769
	=	-76.85 %

Longduoduo Co FCF Margin % Related Terms

Thank you for viewing the detailed overview of Longduoduo Co's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Longduoduo Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Longduoduo Co Ltd (OTCPK:LDDD) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

G3-5-8016, Ruyi Headquarters Base, Hohhot Economic Development Zone, Inner Mongolia, Shui’an, CHN, 010000

Website

http://www.longduoduo.net

Longduoduo Co Ltd through its operating subsidiaries engaged in the business of providing preventive healthcare solutions. It provides a wide range of comprehensive preventive healthcare services including disease screening, healthcare treatments, healthcare products, and other services. The company mainly focuses on the prevention of myocardial infarction, cerebral infarction, hemiplegia, and cardiovascular and cerebrovascular diseases. The company's revenues are generated from its customers in the People's Republic of China.

Longduoduo Co Headlines

No Headlines